Related Experiment Videos
Use of a single silastic i.v. catheter for cystic fibrosis pulmonary exacerbations
1Department of Pediatrics, University of Wisconsin Hospital and Clinics, Madison.
Insights
A single silastic intravenous (IV) catheter provides safe and effective IV access for pediatric cystic fibrosis patients during hospitalizations. This method simplifies care and minimizes complications for extended IV therapy needs.
Area of Science:
- Pediatric Medicine
- Infectious Disease Management
- Medical Device Efficacy
Background:
- Cystic Fibrosis (CF) exacerbations frequently require prolonged intravenous (IV) antibiotic and fluid therapy.
- Maintaining reliable IV access is crucial for effective treatment during CF hospitalizations.
- Traditional IV access methods can be cumbersome and lead to complications in pediatric patients.
Purpose of the Study:
- To evaluate the safety and efficacy of using a single percutaneous silastic IV catheter for all IV needs during CF hospitalizations.
- To assess the duration of catheter patency and identify any complications associated with this approach.
- To determine if this method simplifies IV management for CF patients.
Main Methods:
- A prospective evaluation of 23 pediatric patients with cystic fibrosis (ages 4-20 years) undergoing 45 hospitalizations.
- A single percutaneous silastic IV catheter was used for all IV antibiotics and fluids.
- Catheter dwell times, reasons for removal, and clinical signs of infection or sepsis were recorded.
Main Results:
- Catheters remained in place for a mean of 12.2 days (range 2-34), totaling 549 patient days.
- No patients exhibited clinical signs of local infection or sepsis.
- Thirty-six out of 45 catheters provided continuous access for the entire hospitalization; 9 were removed due to discomfort, obstruction, or mechanical issues.
Conclusions:
- A single, percutaneously placed silastic catheter is a safe and effective method for maintaining IV access in pediatric cystic fibrosis patients.
- This approach can simplify IV management and potentially reduce complications associated with multiple IV insertions.
- The study supports the use of single silastic catheters for prolonged IV therapy in CF exacerbations.
Abstract:
Use of a single percutaneous silastic IV catheter for cystic fibrosis hospitalizations was evaluated among 23 patients during 45 hospitalizations. Patients ages ranged from 4 to 20 years and weights from 18 to 60 kg. Percutaneous silastic catheters were used for infusion of all IV antibiotics and IV fluids. Catheters remained in place for a total of 549 patient days (mean 12.2, range 2-34). No patient demonstrated clinical signs of local infection or sepsis. Thirty six catheters served as the single IV access for a patient's entire hospitalization. Nine catheters were removed because of discomfort, obstruction, or mechanical dysfunction before the conclusion of the hospitalization. A single, percutaneously placed silastic catheter appears to be a safe and effective way of maintaining IV access throughout the duration of hospitalization for cystic fibrosis exacerbations.